KraneShares MSCI All China Health Care Index ETF (KURE)
Data kepemilikan belum tersedia untuk dana ini.
KURE Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 30 Sep. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▲ +1,72% | ▲ +1,72% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Maks | ▲ +2,78% | ▲ +2,78% |
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 63 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| BeOne Medicines AG | H0743H114 | $6.3M | 8,84 | 289.918 | EC | HK |
| INNOVENT BIOLOGICS, INC. | · | $6.3M | 8,80 | 617.500 | EC | HK |
| WUXI BIOLOGICS (CAYMAN) INC. | · | $5.4M | 7,51 | 1.212.635 | EC | HK |
| WuXi AppTec Co., Ltd. | · | $4.1M | 5,79 | 224.720 | EC | CN |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | · | $3.3M | 4,59 | 426.408 | EC | CN |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | · | $3.0M | 4,27 | 152.155 | EC | CN |
| Akeso Inc | · | $2.6M | 3,72 | 236.000 | EC | HK |
| CSPC PHARMACEUTICAL GROUP LIMITED | · | $2.6M | 3,68 | 2.948.889 | EC | HK |
| Invesco Government & Agency Portfolio | 825252885 | $2.5M | 3,55 | 2.526.804 | STIV | US |
| SINO BIOPHARMACEUTICAL LIMITED | · | $2.4M | 3,39 | 4.287.750 | EC | HK |
| WuXi AppTec Co., Ltd. | · | $2.4M | 3,35 | 121.784 | EC | HK |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | · | $2.0M | 2,85 | 538.000 | EC | HK |
| 3SBio Inc. | · | $1.8M | 2,49 | 822.500 | EC | HK |
| YUNNAN BAIYAO GROUP CO., LTD | · | $1.6M | 2,30 | 235.223 | EC | CN |
| Shanghai United Imaging Healthcare Co., Ltd. | · | $1.6M | 2,27 | 108.508 | EC | CN |
| Aier Eye Hospital Group Co., Ltd. | · | $1.5M | 2,10 | 1.227.963 | EC | CN |
| Sichuan Biokin Pharmaceutical Co Ltd | · | $1.4M | 1,97 | 32.322 | EC | CN |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | · | $1.3M | 1,85 | 23.700 | EC | HK |
| ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | · | $1.2M | 1,73 | 76.734 | EC | CN |
| SINOPHARM GROUP CO. LTD. | · | $1.2M | 1,67 | 586.800 | EC | HK |
| Sichuan Kelun Pharmaceutical Co., Ltd. | · | $1.1M | 1,55 | 194.015 | EC | CN |
| Haisco Pharmaceutical Group Co., Ltd. | · | $1.1M | 1,53 | 111.200 | EC | CN |
| HUADONG MEDICINE CO., LTD | · | $969K | 1,36 | 233.941 | EC | CN |
| WuXi XDC Cayman Inc | · | $964K | 1,35 | 132.500 | EC | HK |
| Shanghai Allist Pharmaceuticals Co Ltd | · | $954K | 1,34 | 59.328 | EC | CN |
| Legend Biotech Corp | 52490G102 | $909K | 1,28 | 31.488 | EC | US |
| RemeGen Co Ltd | · | $896K | 1,26 | 46.717 | EC | CN |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | · | $882K | 1,24 | 266.529 | EC | CN |
| Pharmaron Beijing Co., Ltd. | · | $818K | 1,15 | 191.875 | EC | CN |
| Shanghai Pharmaceuticals Holding Co., Ltd. | · | $807K | 1,13 | 355.812 | EC | CN |
| Genscript Biotech Corp | · | $792K | 1,11 | 508.000 | EC | HK |
| RemeGen Co Ltd | · | $748K | 1,05 | 79.000 | EC | HK |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | · | $731K | 1,03 | 220.711 | EC | CN |
| XtalPi Holdings Limited | · | $709K | 1,00 | 727.000 | EC | HK |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | · | $668K | 0,94 | 142.265 | EC | CN |
| Shenzhen New Industries Biomedical Engineering Co Ltd | · | $643K | 0,90 | 103.900 | EC | CN |
| BEIJING TONG REN TANG CO., LTD | · | $614K | 0,86 | 180.490 | EC | CN |
| Shanghai RAAS Blood Products Co., Ltd. | · | $560K | 0,79 | 876.134 | EC | CN |
| Chongqing Zhifei Biological Products Co., Ltd. | · | $543K | 0,76 | 315.472 | EC | CN |
| CSPC Innovation Pharmaceutical Co Ltd | · | $529K | 0,74 | 131.757 | EC | CN |
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | · | $527K | 0,74 | 53.708 | EC | CN |
| Imeik Technology Development Co Ltd | · | $512K | 0,72 | 39.840 | EC | CN |
| APT Medical Inc | · | $497K | 0,70 | 18.599 | EC | CN |
| Beijing Wantai Biological Pharmacy Enterprise Co Ltd | · | $479K | 0,67 | 120.442 | EC | CN |
| Hebei Changshan Biochemical Pharmaceutical Co Ltd | · | $402K | 0,56 | 116.500 | EC | CN |
| Hangzhou Tigermed Consulting Co., Ltd | · | $324K | 0,46 | 45.850 | EC | CN |
| ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | · | $55K | 0,08 | 3.400 | EC | CN |
| Sichuan Kelun Pharmaceutical Co., Ltd. | · | $49K | 0,07 | 8.600 | EC | CN |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | · | $45K | 0,06 | 13.600 | EC | CN |
| Shanghai Pharmaceuticals Holding Co., Ltd. | · | $25K | 0,04 | 11.200 | EC | CN |
Dividen 6 pembayaran
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 22 Des. 2025 | $0,7150 |
| 17 Des. 2024 | $0,1840 |
| 18 Des. 2023 | $0,1130 |
| 28 Des. 2022 | $0,0100 |
| 29 Des. 2021 | $4,0540 |
| 27 Des. 2019 | $0,0570 |
Pemilik institusional (13F) 13 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| Varma Mutual Pension Insurance Co | $23.937.471 | 83,80% | 1.520.129 | Saham | 30 Juni 2026 |
| OLD MISSION CAPITAL LLC | $1.426.630 | 4,99% | 90.597 | Saham | 30 Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.285.680 | 4,50% | 81.646 | Saham | 30 Juni 2026 |
| UBS Group AG | $809.223 | 2,83% | 51.389 | Saham | 30 Juni 2026 |
| Spire Wealth Management | $440.129 | 1,54% | 27.945 | Saham | 30 Juni 2026 |
| Saranac Partners Ltd | $304.405 | 1,07% | 19.331 | Saham | 30 Juni 2026 |
| BANK OF AMERICA CORP /DE/ | $223.607 | 0,78% | 14.200 | Saham | 30 Juni 2026 |
| MORGAN STANLEY | $82.042 | 0,29% | 5.210 | Saham | 30 Juni 2026 |
| Ascentis Wealth Management, LLC | $28.076 | 0,10% | 1.783 | Saham | 30 Juni 2026 |
| Financial Perspectives, Inc | $26.190 | 0,09% | 1.663 | Saham | 30 Juni 2026 |
| ROYAL BANK OF CANADA | $1.000 | 0,00% | 88 | Saham | 30 Juni 2026 |
| EverSource Wealth Advisors, LLC | $88 | 0,00% | 6 | Saham | 30 Juni 2026 |
| FMR LLC | $31 | 0,00% | 2 | Saham | 30 Juni 2026 |